Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review protocol.
Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review protocol.
复制标题
DOI：
10.1136/bmjopen-2020-044093
复制
发表时间：
2021-05-06
期刊：
影响因子：
2.9
通讯作者：
Moodley J
中科院分区：
文献类型：
--
作者：
Nnaji CA;Kuodi P;Walter FM;Moodley J
乳腺癌和宫颈癌是全球女性发病和死亡的主要原因，低收入和中等收入国家 (LMIC) 的负担尤其高。尽管这两种癌症的发病率在中低收入国家中有所增加，但许多病例仍然未被诊断或诊断较晚。本综述的目的是全面绘制中低收入国家乳腺癌或宫颈癌诊断时间及其相关因素的当前证据。 Arksey 和 O'Malley 的增强型 ScR 方法框架将为本次范围界定审查 (ScR) 提供信息。将根据系统审查的首选报告项目和范围审查的元分析扩展进行报告。我们将对以下电子数据库进行全面检索：MEDLINE（通过 PubMed）、Cochrane 图书馆、Scopus 以及护理和联合健康文献累积索引 (CINAHL)。两名审稿人将使用预定义的纳入标准独立筛选所有摘要和全文。所有描述乳腺癌或宫颈癌诊断时间及其相关因素的出版物都将被考虑纳入。将使用预定义的概念框架对证据进行叙述性综合和分析。由于这是公开数据的 ScR，没有主要数据收集，因此不需要道德批准。研究结果将通过同行评审的出版物和论坛（例如会议和社区参与会议）广泛传播。本次审查将提供一个用户友好的证据摘要，以了解中低收入国家乳腺癌和宫颈癌诊断延迟的严重性以及相关因素，同时帮助为解决此类延迟的政策行动和干预措施的实施提供信息。
Breast and cervical cancer are leading causes of morbidity and mortality in women globally, with disproportionately high burdens in low-income and middle-income countries (LMICs). While the incidence of both cancers increases across LMICs, many cases continue to go undiagnosed or diagnosed late. The aim of this review is to comprehensively map the current evidence on the time to breast or cervical cancer diagnosis and its associated factors in LMICs. This scoping review (ScR) will be informed by Arksey and O'Malley’s enhanced ScR methodology framework. It will be reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews. We will conduct a comprehensive search of the following electronic databases: MEDLINE (via PubMed), Cochrane Library, Scopus and the Cumulative Index to Nursing and Allied Health Literature (CINAHL). Two reviewers will independently screen all abstracts and full texts using predefined inclusion criteria. All publications describing the time to diagnosis and its associated factors in the contexts of breast or cervical cancer will be considered for inclusion. Evidence will be narratively synthesised and analysed using a predefined conceptual framework. As this is a ScR of publicly available data, with no primary data collection, it will not require ethical approval. Findings will be disseminated widely through a peer-reviewed publication and forums such as conferences and community engagement sessions. This review will provide a user-friendly evidence summary for understanding the enormity of diagnostic delays and associated factors for breast and cervical cancers in LMICs, while helping to inform policy actions and implementation of interventions for addressing such delays.
登录
查看更多内容
影响因子：
3.8
作者：
Moodley, Jennifer;Cairncross, Lydia;Constant, Deborah
通讯作者：
Constant, Deborah
影响因子：
1.8
作者：
Carlos Lopes-Júnior, Luís;Cruz, Lóris Aparecida Prado da;Silveira, Renata Cristina de Campos Pereira
通讯作者：
Silveira, Renata Cristina de Campos Pereira
DOI：
10.1186/1748-5908-5-69
发表时间：
2010-09-20
期刊：
Implementation science : IS
影响因子：
--
作者：
Levac D;Colquhoun H;O'Brien KK
通讯作者：
O'Brien KK
影响因子：
3.7
作者：
Grosse Frie K;Kamaté B;Traoré CB;Ly M;Mallé B;Coulibaly B;Wienke A;Kantelhardt EJ
通讯作者：
Kantelhardt EJ
影响因子：
2.9
作者：
Moodley, Jennifer;Cairncross, Lydia;Momberg, Mariette
通讯作者：
Momberg, Mariette